Table 2.
Feature | Number | % | p* |
---|---|---|---|
Sex | 0.074 | ||
Male | 14 | 70 | |
Female | 6 | 30 | |
Pathological T | 0.022 | ||
T1b | 6 | 30 | |
T2b | 14 | 70 | |
Histologic grade | 0.387 | ||
G1 | 4 | 20 | |
G2 | 7 | 35 | |
G3 | 9 | 45 | |
Clinical stage | 0.199 | ||
IA | 1 | 5 | |
IB | 3 | 15 | |
IIA | 3 | 15 | |
IIB | 6 | 30 | |
III | 7 | 35 | |
IV | 0 | 0 | |
Initial treatment | 0.035 | ||
Surgery | 12 | 60 | |
Chemotherapy | 3 | 15 | |
Radiotherapy + chemotherapy | 5 | 25 | |
Resection (13 patients) | 0.166+ | ||
R0 | 9 | 69 | |
R1 | 4 | 31 | |
Reconstruction | 8 | 61 | |
Recurrence | 6 | ||
Adjuvant therapy | 46 | ||
No | 7 | 35 | |
Radiotherapy | 12 | 60 | |
Chemotherapy | 1 | 5 |
* Pearson’s χ2 + Only R0 versus R1